Portfolio Holdings Detail for ISIN IE00B3ZW0K18
Stock Name / Fund iShares S&P 500 EUR Hedged UCITS ETF (Acc)
Issuer Blackrock
Entity holding fund iShares V Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300QETNU1W5JY7Z94
ETF Ticker IBCF(EUR) F
ETF Ticker IUES.AS(EUR) CXE
ETF Ticker IUSE.L(EUR) CXE
ETF Ticker IUSE.MI(EUR) CXE
ETF Ticker IUSEz(EUR) CXE
ETF Ticker IUSE(EUR) ETF Plus

Holdings detail for TECH

Stock Name	Bio-Techne Corp
Ticker	TECH(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US09073M1045
LEI	54930073RLKQ51TILZ35

Show aggregate TECH holdings

News associated with TECH

Royal Bank Of Canada Upgrades Bio-Techne (NASDAQ:TECH) to “Moderate Buy”: Bio-Techne (NASDAQ:TECH – Get Free Report) was upgraded by equities research analysts at Royal Bank Of Canada from a “hold” rating to a “moderate buy” rating in a research note issued on Wednesday,Zacks.com reports. Several other analysts have also recently issued reports on TECH. UBS Group lowered their target price on shares of Bio-Techne from […] - 2025-09-05 05:36:53
Bio-Techne Corp (NASDAQ:TECH) Shares Acquired by Charles Schwab Investment Management Inc.: Charles Schwab Investment Management Inc. lifted its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.1% in the first quarter, according to the company in its most recent disclosure with the SEC. The institutional investor owned 1,511,260 shares of the biotechnology company’s stock after buying an additional 45,570 shares during the quarter. […] - 2025-08-13 05:12:55
How The Pieces Add Up: TCAF Headed For $40: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-07-29 10:39:29
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Cwm LLC: Cwm LLC cut its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 6.2% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 11,927 shares of the biotechnology company’s stock after selling 786 shares during the quarter. Cwm LLC’s holdings in Bio-Techne […] - 2025-07-24 04:47:00
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Signaturefd LLC: Signaturefd LLC decreased its holdings in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 9.8% in the first quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,690 shares of the biotechnology company’s stock after selling 293 shares during the quarter. Signaturefd LLC’s holdings in Bio-Techne were […] - 2025-07-21 05:43:00
Mutual of America Capital Management LLC Has $3.25 Million Stock Holdings in Bio-Techne Corp (NASDAQ:TECH): Mutual of America Capital Management LLC raised its holdings in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 29.8% in the 1st quarter, HoldingsChannel reports. The fund owned 55,493 shares of the biotechnology company’s stock after acquiring an additional 12,740 shares during the period. Mutual of America Capital Management LLC’s holdings in Bio-Techne were worth $3,254,000 […] - 2025-07-18 05:16:49
Bio-Techne Corp (NASDAQ:TECH) Shares Bought by Xponance Inc.: Xponance Inc. increased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.0% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 21,540 shares of the biotechnology company’s stock after purchasing an additional 619 shares during the period. Xponance […] - 2025-07-16 06:24:53
Cerity Partners LLC Grows Position in Bio-Techne Corp (NASDAQ:TECH): Cerity Partners LLC raised its position in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 20.1% in the 1st quarter, HoldingsChannel.com reports. The institutional investor owned 132,742 shares of the biotechnology company’s stock after purchasing an additional 22,259 shares during the quarter. Cerity Partners LLC’s holdings in Bio-Techne were worth $7,783,000 at the end […] - 2025-07-16 05:38:08
DekaBank Deutsche Girozentrale Sells 261 Shares of Bio-Techne Corp (NASDAQ:TECH): DekaBank Deutsche Girozentrale lowered its position in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 1.4% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,926 shares of the biotechnology company’s stock after selling 261 shares during the quarter. DekaBank Deutsche […] - 2025-07-14 05:34:48
Bio-Techne Corp (NASDAQ:TECH) Shares Sold by Vontobel Holding Ltd.: Vontobel Holding Ltd. lessened its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 5.1% during the first quarter, HoldingsChannel reports. The fund owned 4,960 shares of the biotechnology company’s stock after selling 269 shares during the period. Vontobel Holding Ltd.’s holdings in Bio-Techne were worth $291,000 at the end of the most […] - 2025-07-09 05:02:49
GAMMA Investing LLC Lowers Stake in Bio-Techne Corp (NASDAQ:TECH): GAMMA Investing LLC reduced its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 38.0% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,795 shares of the biotechnology company’s stock after selling 1,101 shares during the quarter. GAMMA Investing LLC’s holdings in […] - 2025-07-07 04:17:11
Bio-Techne Corp (NASDAQ:TECH) Shares Purchased by Janney Montgomery Scott LLC: Janney Montgomery Scott LLC raised its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 4.6% during the 1st quarter, Holdings Channel reports. The firm owned 11,210 shares of the biotechnology company’s stock after acquiring an additional 490 shares during the quarter. Janney Montgomery Scott LLC’s holdings in Bio-Techne were worth $657,000 at the end […] - 2025-07-02 05:43:07
Bio-Techne Corp (NASDAQ:TECH) Shares Purchased by Diversified Trust Co: Diversified Trust Co grew its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 10.0% in the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 13,824 shares of the biotechnology company’s stock after buying an additional 1,260 shares during the quarter. […] - 2025-06-30 05:10:55
Bessemer Group Inc. Sells 61,323 Shares of Bio-Techne Corp (NASDAQ:TECH): Bessemer Group Inc. decreased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 75.6% in the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,748 shares of the biotechnology company’s stock after selling 61,323 shares during the quarter. Bessemer […] - 2025-06-30 04:38:49
Chevy Chase Trust Holdings LLC Sells 2,582 Shares of Bio-Techne Corp (NASDAQ:TECH): Chevy Chase Trust Holdings LLC cut its position in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 3.0% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 82,909 shares of the biotechnology company’s stock after selling 2,582 shares during the quarter. Chevy Chase Trust […] - 2025-06-27 05:12:48
Retirement Systems of Alabama Sells 430 Shares of Bio-Techne Corp (NASDAQ:TECH): Retirement Systems of Alabama lessened its stake in Bio-Techne Corp (NASDAQ:TECH – Free Report) by 1.2% in the first quarter, HoldingsChannel reports. The firm owned 33,972 shares of the biotechnology company’s stock after selling 430 shares during the period. Retirement Systems of Alabama’s holdings in Bio-Techne were worth $1,992,000 at the end of the most […] - 2025-06-26 06:06:47
Bio-Techne Corp (NASDAQ:TECH) Shares Acquired by Oppenheimer Asset Management Inc.: Oppenheimer Asset Management Inc. increased its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 4.6% in the first quarter, Holdings Channel reports. The firm owned 67,166 shares of the biotechnology company’s stock after acquiring an additional 2,929 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Bio-Techne were worth $3,938,000 at […] - 2025-06-26 05:16:55
Bio-Techne Corp (NASDAQ:TECH) Shares Bought by Exchange Traded Concepts LLC: Exchange Traded Concepts LLC lifted its stake in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 21.2% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,803 shares of the biotechnology company’s stock after buying an additional 490 shares during the quarter. Exchange […] - 2025-06-24 04:36:51
CX Institutional Invests $27,000 in Bio-Techne Corp (NASDAQ:TECH): CX Institutional acquired a new position in Bio-Techne Corp (NASDAQ:TECH – Free Report) in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 459 shares of the biotechnology company’s stock, valued at approximately $27,000. Several other large investors also […] - 2025-06-19 04:52:57
Bio-Techne Corp (NASDAQ:TECH) Receives Consensus Rating of “Hold” from Brokerages: Bio-Techne Corp (NASDAQ:TECH – Get Free Report) has earned an average recommendation of “Hold” from the eleven analysts that are presently covering the firm, MarketBeat reports. Six equities research analysts have rated the stock with a hold recommendation and five have given a buy recommendation to the company. The average 1-year price objective among analysts […] - 2025-06-18 06:12:46
Mn Services Vermogensbeheer B.V. Sells 6,200 Shares of Bio-Techne Corp (NASDAQ:TECH): Mn Services Vermogensbeheer B.V. trimmed its holdings in shares of Bio-Techne Corp (NASDAQ:TECH – Free Report) by 9.9% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 56,200 shares of the biotechnology company’s stock after selling 6,200 shares during the quarter. Mn Services […] - 2025-06-18 05:32:53
Bio-Techne (NASDAQ:TECH) Cut to Hold at Wall Street Zen: Wall Street Zen lowered shares of Bio-Techne (NASDAQ:TECH – Free Report) from a buy rating to a hold rating in a research note issued to investors on Sunday. Several other analysts have also commented on the stock. Citigroup lowered their price target on shares of Bio-Techne from $80.00 to $70.00 and set a “neutral” rating […] - 2025-06-09 03:44:45
Rhumbline Advisers Increases Position in Bio-Techne Co. (NASDAQ:TECH): Rhumbline Advisers lifted its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 15.1% during the first quarter, Holdings Channel.com reports. The institutional investor owned 300,474 shares of the biotechnology company’s stock after acquiring an additional 39,345 shares during the quarter. Rhumbline Advisers’ holdings in Bio-Techne were worth $17,617,000 as of its most recent filing […] - 2025-06-08 05:35:05
Squarepoint Ops LLC Buys 4,816 Shares of Bio-Techne Co. (NASDAQ:TECH): Squarepoint Ops LLC boosted its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 113.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 9,060 shares of the biotechnology company’s stock after buying an additional 4,816 shares during […] - 2025-06-03 05:06:58
Universal Beteiligungs und Servicegesellschaft mbH Invests $4.08 Million in Bio-Techne Co. (NASDAQ:TECH): Universal Beteiligungs und Servicegesellschaft mbH acquired a new position in Bio-Techne Co. (NASDAQ:TECH – Free Report) during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund acquired 56,666 shares of the biotechnology company’s stock, valued at approximately $4,082,000. Other hedge funds and other institutional investors […] - 2025-06-02 05:36:54
Bio-Techne Co. (NASDAQ:TECH) Shares Sold by Two Sigma Advisers LP: Two Sigma Advisers LP trimmed its stake in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 4.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 17,900 shares of the biotechnology company’s stock after selling 900 shares during the quarter. Two Sigma Advisers […] - 2025-06-01 05:44:50
How The Parts Add Up: XLV Headed For $158: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-05-26 08:22:41
Cetera Investment Advisers Decreases Position in Bio-Techne Co. (NASDAQ:TECH): Cetera Investment Advisers lessened its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 4.3% during the fourth quarter, Holdings Channel.com reports. The firm owned 19,857 shares of the biotechnology company’s stock after selling 887 shares during the quarter. Cetera Investment Advisers’ holdings in Bio-Techne were worth $1,430,000 at the end of the most recent […] - 2025-05-22 04:52:55
Bank of America Corp DE Sells 303,523 Shares of Bio-Techne Co. (NASDAQ:TECH): Bank of America Corp DE cut its holdings in Bio-Techne Co. (NASDAQ:TECH – Free Report) by 37.0% during the 4th quarter, Holdings Channel reports. The fund owned 516,549 shares of the biotechnology company’s stock after selling 303,523 shares during the period. Bank of America Corp DE’s holdings in Bio-Techne were worth $37,207,000 as of its […] - 2025-05-16 05:31:04
Mercer Global Advisors Inc. ADV Reduces Stake in Bio-Techne Co. (NASDAQ:TECH): Mercer Global Advisors Inc. ADV decreased its stake in shares of Bio-Techne Co. (NASDAQ:TECH – Free Report) by 15.7% during the fourth quarter, HoldingsChannel.com reports. The firm owned 4,028 shares of the biotechnology company’s stock after selling 751 shares during the period. Mercer Global Advisors Inc. ADV’s holdings in Bio-Techne were worth $290,000 at the […] - 2025-05-16 04:49:06

iShares S&P 500 EUR Hedged UCITS ETF (Acc) TECH holdings

Date	Number of TECH Shares Held	Base Market Value of TECH Shares	Local Market Value of TECH Shares	Change in TECH Shares Held	Change in TECH Base Value	Current Price per TECH Share Held	Previous Price per TECH Share Held
2025-09-18 (Thursday)	22,484	USD 1,011,742	USD 1,011,742	0	USD 34,210	USD 44.9983	USD 43.4768
2025-09-17 (Wednesday)	22,484	USD 977,532	USD 977,532	0	USD -4,768	USD 43.4768	USD 43.6888
2025-09-16 (Tuesday)	22,484	USD 982,300	USD 982,300	33	USD -3,344	USD 43.6888	USD 43.902
2025-09-15 (Monday)	22,451	USD 985,644	USD 985,644
2025-09-12 (Friday)	22,418	USD 979,915	USD 979,915
2025-09-11 (Thursday)	22,418	USD 1,017,106	USD 1,017,106	0	USD 42,967	USD 45.3701	USD 43.4534
2025-09-10 (Wednesday)	22,418	USD 974,139	USD 974,139
2025-09-09 (Tuesday)	22,352	USD 1,032,671	USD 1,032,671
2025-09-08 (Monday)	22,352	USD 1,029,772	USD 1,029,772

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of TECH by Blackrock for IE00B3ZW0K18

Show aggregate share trades of TECH

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-16 BUY 33 43.689* 55.13
2025-08-21 BUY 33 46.486* 55.23
2025-08-20 SELL -66 46.583* 55.28 Profit of 3,648 on sale
2025-08-13 BUY 66 46.683* 55.38
2025-08-12 BUY 33 45.315* 55.43
2025-08-08 SELL -33 43.257* 55.57 Profit of 1,834 on sale
2025-08-05 BUY 66 47.242* 55.68
2025-08-04 SELL -132 47.456* 55.73 Profit of 7,357 on sale
2025-08-01 SELL -33 47.505* 55.78 Profit of 1,841 on sale
2025-07-31 BUY 99 47.818* 55.82
2025-07-30 BUY 33 50.270* 55.86
2025-07-18 SELL -99 44.662* 56.18 Profit of 5,562 on sale
2025-07-16 SELL -66 44.660* 56.31 Profit of 3,717 on sale
2025-07-10 BUY 33 46.582* 56.58
2025-07-07 BUY 66 43.903* 56.81
2025-07-02 BUY 33 45.192* 57.03
2025-06-24 BUY 66 43.040* 57.45
2025-06-23 BUY 33 42.756* 57.55
2025-06-18 BUY 33 43.559* 57.84
2025-06-17 BUY 33 42.943* 57.94
2025-06-05 SELL -66 42.165* 58.75 Profit of 3,878 on sale
2025-06-03 BUY 66 42.818* 58.98
2025-05-28 BUY 363 42.408* 59.48
2025-05-27 BUY 99 42.931* 59.61
2025-05-22 SELL -33 41.956* 60.03 Profit of 1,981 on sale
2025-05-21 SELL -33 41.143* 60.18 Profit of 1,986 on sale
2025-05-20 SELL -66 43.954* 60.31 Profit of 3,980 on sale
2025-05-19 SELL -66 43.791* 60.44 Profit of 3,989 on sale
2025-05-15 BUY 33 43.122* 60.72
2025-05-14 BUY 66 42.681* 60.86
2025-05-13 BUY 99 46.235* 60.98
2025-05-12 BUY 198 48.506* 61.09
2025-05-09 BUY 99 44.318* 61.23
2025-05-02 BUY 33 44.410* 62.01
2025-04-28 BUY 33 44.160* 62.65
2025-04-25 SELL -33 44.192* 62.82 Profit of 2,073 on sale
2025-04-24 BUY 99 44.648* 62.99
2025-04-23 BUY 33 44.194* 63.17
2025-04-22 BUY 33 42.760* 63.36
2025-04-16 SELL -33 43.905* 64.18 Profit of 2,118 on sale
2025-04-15 BUY 33 45.083* 64.37
2025-04-14 BUY 66 46.215* 64.55
2025-04-11 BUY 66 44.733* 64.75
2025-04-10 BUY 33 44.059* 64.96
2025-04-09 BUY 33 48.983* 65.13
2025-04-08 BUY 66 44.735* 65.34
2025-04-07 SELL -33 47.892* 65.52 Profit of 2,162 on sale
2025-04-04 SELL -198 47.067* 65.72 Profit of 13,012 on sale
2025-04-01 SELL -66 53.050* 65.99 Profit of 4,355 on sale
2025-03-31 SELL -66 54.277* 66.11 Profit of 4,364 on sale
2025-03-28 SELL -66 54.264* 66.25 Profit of 4,372 on sale
2025-03-25 BUY 33 55.535* 66.62
2025-03-21 SELL -132 56.074* 66.86 Profit of 8,826 on sale
2025-03-20 SELL -99 55.628* 67.00 Profit of 6,633 on sale
2025-03-18 BUY 198 57.500* 67.25
2025-03-11 SELL -33 53.510* 68.00 Profit of 2,244 on sale
2025-03-10 SELL -99 58.039* 68.13 Profit of 6,745 on sale
2025-03-07 SELL -231 59.218* 68.25 Profit of 15,766 on sale
2025-03-05 SELL -99 57.785* 68.39 Profit of 6,771 on sale
2025-03-03 SELL -132 58.357* 68.69 Profit of 9,067 on sale
2025-02-27 SELL -33 58.802* 68.96 Profit of 2,276 on sale
2025-02-19 BUY 33 63.124* 69.60
2025-02-18 BUY 66 62.377* 69.72
2025-02-13 BUY 66 63.996* 70.04
2025-02-05 SELL -264 72.207* 70.16 Profit of 18,523 on sale
2025-02-04 BUY 33 69.891* 70.17
2025-01-29 BUY 33 68.935* 70.20
2025-01-28 BUY 33 71.562* 70.17
2025-01-24 BUY 99 73.255* 70.04
2025-01-23 BUY 231 73.970* 69.96
2025-01-22 BUY 165 75.541* 69.83
2025-01-21 BUY 33 75.718* 69.69
2025-01-16 BUY 198 73.880* 69.41
2025-01-15 BUY 33 72.903* 69.32
2025-01-10 BUY 33 71.525* 69.01
2024-12-10 BUY 33 73.416* 68.64
2024-12-09 BUY 132 73.074* 68.50
2024-12-05 SELL -66 69.882* 68.38 Profit of 4,513 on sale
2024-12-04 BUY 99 72.074* 68.26
2024-12-03 SELL -165 71.357* 68.14 Profit of 11,244 on sale
2024-12-02 BUY 66 72.611* 67.98
2024-11-25 BUY 66 70.925* 67.23
2024-11-22 SELL -33 68.473* 67.17 Profit of 2,217 on sale
2024-11-21 SELL -33 67.596* 67.15 Profit of 2,216 on sale
2024-11-18 BUY 165 63.234* 67.75
2024-11-12 BUY 33 70.135* 67.60
2024-11-08 BUY 231 70.667* 67.20
2024-11-07 BUY 66 70.681* 66.93
2024-11-06 BUY 33 70.615* 66.62
2024-10-31 BUY 99 67.932* 65.16
2024-10-29 BUY 33 65.509* 64.30
2024-10-28 BUY 33 65.055* 64.15
2024-10-25 BUY 33 63.408* 64.33
2024-10-24 BUY 33 63.320* 64.67
2024-10-23 SELL -66 64.353* 64.82 Profit of 4,278 on sale
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-16	BUY	33	43.689*	55.13
2025-08-21	BUY	33	46.486*	55.23
2025-08-20	SELL	-66	46.583*	55.28 Profit of 3,648 on sale
2025-08-13	BUY	66	46.683*	55.38
2025-08-12	BUY	33	45.315*	55.43
2025-08-08	SELL	-33	43.257*	55.57 Profit of 1,834 on sale
2025-08-05	BUY	66	47.242*	55.68
2025-08-04	SELL	-132	47.456*	55.73 Profit of 7,357 on sale
2025-08-01	SELL	-33	47.505*	55.78 Profit of 1,841 on sale
2025-07-31	BUY	99	47.818*	55.82
2025-07-30	BUY	33	50.270*	55.86
2025-07-18	SELL	-99	44.662*	56.18 Profit of 5,562 on sale
2025-07-16	SELL	-66	44.660*	56.31 Profit of 3,717 on sale
2025-07-10	BUY	33	46.582*	56.58
2025-07-07	BUY	66	43.903*	56.81
2025-07-02	BUY	33	45.192*	57.03
2025-06-24	BUY	66	43.040*	57.45
2025-06-23	BUY	33	42.756*	57.55
2025-06-18	BUY	33	43.559*	57.84
2025-06-17	BUY	33	42.943*	57.94
2025-06-05	SELL	-66	42.165*	58.75 Profit of 3,878 on sale
2025-06-03	BUY	66	42.818*	58.98
2025-05-28	BUY	363	42.408*	59.48
2025-05-27	BUY	99	42.931*	59.61
2025-05-22	SELL	-33	41.956*	60.03 Profit of 1,981 on sale
2025-05-21	SELL	-33	41.143*	60.18 Profit of 1,986 on sale
2025-05-20	SELL	-66	43.954*	60.31 Profit of 3,980 on sale
2025-05-19	SELL	-66	43.791*	60.44 Profit of 3,989 on sale
2025-05-15	BUY	33	43.122*	60.72
2025-05-14	BUY	66	42.681*	60.86
2025-05-13	BUY	99	46.235*	60.98
2025-05-12	BUY	198	48.506*	61.09
2025-05-09	BUY	99	44.318*	61.23
2025-05-02	BUY	33	44.410*	62.01
2025-04-28	BUY	33	44.160*	62.65
2025-04-25	SELL	-33	44.192*	62.82 Profit of 2,073 on sale
2025-04-24	BUY	99	44.648*	62.99
2025-04-23	BUY	33	44.194*	63.17
2025-04-22	BUY	33	42.760*	63.36
2025-04-16	SELL	-33	43.905*	64.18 Profit of 2,118 on sale
2025-04-15	BUY	33	45.083*	64.37
2025-04-14	BUY	66	46.215*	64.55
2025-04-11	BUY	66	44.733*	64.75
2025-04-10	BUY	33	44.059*	64.96
2025-04-09	BUY	33	48.983*	65.13
2025-04-08	BUY	66	44.735*	65.34
2025-04-07	SELL	-33	47.892*	65.52 Profit of 2,162 on sale
2025-04-04	SELL	-198	47.067*	65.72 Profit of 13,012 on sale
2025-04-01	SELL	-66	53.050*	65.99 Profit of 4,355 on sale
2025-03-31	SELL	-66	54.277*	66.11 Profit of 4,364 on sale
2025-03-28	SELL	-66	54.264*	66.25 Profit of 4,372 on sale
2025-03-25	BUY	33	55.535*	66.62
2025-03-21	SELL	-132	56.074*	66.86 Profit of 8,826 on sale
2025-03-20	SELL	-99	55.628*	67.00 Profit of 6,633 on sale
2025-03-18	BUY	198	57.500*	67.25
2025-03-11	SELL	-33	53.510*	68.00 Profit of 2,244 on sale
2025-03-10	SELL	-99	58.039*	68.13 Profit of 6,745 on sale
2025-03-07	SELL	-231	59.218*	68.25 Profit of 15,766 on sale
2025-03-05	SELL	-99	57.785*	68.39 Profit of 6,771 on sale
2025-03-03	SELL	-132	58.357*	68.69 Profit of 9,067 on sale
2025-02-27	SELL	-33	58.802*	68.96 Profit of 2,276 on sale
2025-02-19	BUY	33	63.124*	69.60
2025-02-18	BUY	66	62.377*	69.72
2025-02-13	BUY	66	63.996*	70.04
2025-02-05	SELL	-264	72.207*	70.16 Profit of 18,523 on sale
2025-02-04	BUY	33	69.891*	70.17
2025-01-29	BUY	33	68.935*	70.20
2025-01-28	BUY	33	71.562*	70.17
2025-01-24	BUY	99	73.255*	70.04
2025-01-23	BUY	231	73.970*	69.96
2025-01-22	BUY	165	75.541*	69.83
2025-01-21	BUY	33	75.718*	69.69
2025-01-16	BUY	198	73.880*	69.41
2025-01-15	BUY	33	72.903*	69.32
2025-01-10	BUY	33	71.525*	69.01
2024-12-10	BUY	33	73.416*	68.64
2024-12-09	BUY	132	73.074*	68.50
2024-12-05	SELL	-66	69.882*	68.38 Profit of 4,513 on sale
2024-12-04	BUY	99	72.074*	68.26
2024-12-03	SELL	-165	71.357*	68.14 Profit of 11,244 on sale
2024-12-02	BUY	66	72.611*	67.98
2024-11-25	BUY	66	70.925*	67.23
2024-11-22	SELL	-33	68.473*	67.17 Profit of 2,217 on sale
2024-11-21	SELL	-33	67.596*	67.15 Profit of 2,216 on sale
2024-11-18	BUY	165	63.234*	67.75
2024-11-12	BUY	33	70.135*	67.60
2024-11-08	BUY	231	70.667*	67.20
2024-11-07	BUY	66	70.681*	66.93
2024-11-06	BUY	33	70.615*	66.62
2024-10-31	BUY	99	67.932*	65.16
2024-10-29	BUY	33	65.509*	64.30
2024-10-28	BUY	33	65.055*	64.15
2024-10-25	BUY	33	63.408*	64.33
2024-10-24	BUY	33	63.320*	64.67
2024-10-23	SELL	-66	64.353*	64.82 Profit of 4,278 on sale

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of TECH

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	651,351	11,081	870,856	74.8%
2025-09-18	364,726	0	635,897	57.4%
2025-09-17	271,704	109	711,345	38.2%
2025-09-16	359,432	0	1,639,778	21.9%
2025-09-15	279,701	30	759,619	36.8%
2025-09-12	389,406	1,558	859,942	45.3%
2025-09-11	291,397	29	720,351	40.5%
2025-09-10	623,442	21	1,428,220	43.7%
2025-09-09	496,573	317	1,091,069	45.5%
2025-09-08	324,673	215	797,101	40.7%
2025-09-05	300,894	351	736,450	40.9%
2025-09-04	298,145	50	849,327	35.1%
2025-09-03	396,446	0	721,672	54.9%
2025-09-02	157,804	0	635,177	24.8%
2025-08-29	267,604	3,210	620,568	43.1%
2025-08-28	552,631	0	1,621,664	34.1%
2025-08-27	319,849	448	770,759	41.5%
2025-08-26	501,622	768	647,137	77.5%
2025-08-25	403,253	775	980,209	41.1%
2025-08-22	345,299	759	513,182	67.3%
2025-08-21	321,840	4	618,184	52.1%
2025-08-20	340,427	5	602,034	56.5%
2025-08-19	355,234	0	523,537	67.9%
2025-08-18	257,251	0	489,732	52.5%
2025-08-15	172,735	2	321,976	53.6%
2025-08-14	267,327	265	566,986	47.1%
2025-08-13	301,960	36	655,814	46.0%
2025-08-12	336,423	93	800,318	42.0%
2025-08-11	335,295	637	799,433	41.9%
2025-08-08	425,181	21,371	853,695	49.8%
2025-08-07	562,062	46,894	1,314,238	42.8%
2025-08-06	1,493,783	12,282	3,400,018	43.9%
2025-08-05	325,305	5,603	950,698	34.2%
2025-08-04	295,321	1,870	616,199	47.9%
2025-08-01	382,016	10,466	684,127	55.8%
2025-07-31	403,777	1,690	959,800	42.1%
2025-07-30	313,857	6,379	528,864	59.3%
2025-07-29	438,326	2,402	761,350	57.6%
2025-07-28	682,925	6,900	1,041,300	65.6%
2025-07-25	615,597	26,371	1,044,882	58.9%
2025-07-24	1,073,712	63,037	2,073,185	51.8%
2025-07-23	529,319	3,724	1,012,041	52.3%
2025-07-22	346,582	2,688	608,362	57.0%
2025-07-21	871,045	4	1,362,951	63.9%
2025-07-18	384,062	1,700	787,478	48.8%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares S&P 500 EUR Hedged UCITS ETF (Acc)
Issuer	Blackrock
Entity holding fund	iShares V Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300QETNU1W5JY7Z94
ETF Ticker	IBCF(EUR) F
ETF Ticker	IUES.AS(EUR) CXE
ETF Ticker	IUSE.L(EUR) CXE
ETF Ticker	IUSE.MI(EUR) CXE
ETF Ticker	IUSEz(EUR) CXE
ETF Ticker	IUSE(EUR) ETF Plus